Cargando…
Outcome measures of phase III anticancer drug trials in China
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278717/ https://www.ncbi.nlm.nih.gov/pubmed/37026851 http://dx.doi.org/10.1097/CM9.0000000000002264 |
| _version_ | 1785060536118935552 |
|---|---|
| author | Guo, Lanwei Huang, Huiyao Yu, Yue Wang, Jun Wang, Le Wang, Shuhang Wu, Dawei Fang, Yuan Jiang, Ning Zhang, Shaokai Tang, Yu Li, Ning |
| author_facet | Guo, Lanwei Huang, Huiyao Yu, Yue Wang, Jun Wang, Le Wang, Shuhang Wu, Dawei Fang, Yuan Jiang, Ning Zhang, Shaokai Tang, Yu Li, Ning |
| author_sort | Guo, Lanwei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10278717 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102787172023-06-20 Outcome measures of phase III anticancer drug trials in China Guo, Lanwei Huang, Huiyao Yu, Yue Wang, Jun Wang, Le Wang, Shuhang Wu, Dawei Fang, Yuan Jiang, Ning Zhang, Shaokai Tang, Yu Li, Ning Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-04-07 2023-04-20 /pmc/articles/PMC10278717/ /pubmed/37026851 http://dx.doi.org/10.1097/CM9.0000000000002264 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Correspondence Guo, Lanwei Huang, Huiyao Yu, Yue Wang, Jun Wang, Le Wang, Shuhang Wu, Dawei Fang, Yuan Jiang, Ning Zhang, Shaokai Tang, Yu Li, Ning Outcome measures of phase III anticancer drug trials in China |
| title | Outcome measures of phase III anticancer drug trials in China |
| title_full | Outcome measures of phase III anticancer drug trials in China |
| title_fullStr | Outcome measures of phase III anticancer drug trials in China |
| title_full_unstemmed | Outcome measures of phase III anticancer drug trials in China |
| title_short | Outcome measures of phase III anticancer drug trials in China |
| title_sort | outcome measures of phase iii anticancer drug trials in china |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278717/ https://www.ncbi.nlm.nih.gov/pubmed/37026851 http://dx.doi.org/10.1097/CM9.0000000000002264 |
| work_keys_str_mv | AT guolanwei outcomemeasuresofphaseiiianticancerdrugtrialsinchina AT huanghuiyao outcomemeasuresofphaseiiianticancerdrugtrialsinchina AT yuyue outcomemeasuresofphaseiiianticancerdrugtrialsinchina AT wangjun outcomemeasuresofphaseiiianticancerdrugtrialsinchina AT wangle outcomemeasuresofphaseiiianticancerdrugtrialsinchina AT wangshuhang outcomemeasuresofphaseiiianticancerdrugtrialsinchina AT wudawei outcomemeasuresofphaseiiianticancerdrugtrialsinchina AT fangyuan outcomemeasuresofphaseiiianticancerdrugtrialsinchina AT jiangning outcomemeasuresofphaseiiianticancerdrugtrialsinchina AT zhangshaokai outcomemeasuresofphaseiiianticancerdrugtrialsinchina AT tangyu outcomemeasuresofphaseiiianticancerdrugtrialsinchina AT lining outcomemeasuresofphaseiiianticancerdrugtrialsinchina |